| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.25 | 2e-08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |